Literature DB >> 10941490

[Hemolytic anemia in a newborn after maternal treatment with nitrofurantoin at the end of pregnancy].

H Bruel1, V Guillemant, C Saladin-Thiron, J P Chabrolle, A Lahary, J Poinsot.   

Abstract

UNLABELLED: Drug administration during the last trimester of pregnancy may have adverse effects for the newborn. CASE REPORT: A hemolytic anemia occurred during the first hours of life in a full-term neonate whose mother had taken nitrofurantoin during the last month of pregnancy.
CONCLUSION: The immature enzymatic systems of the neonate are exposed to this adverse effect and justify the recommendation not to prescribe nitrofurantoin at the end of pregnancy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10941490     DOI: 10.1016/s0929-693x(00)80155-4

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  3 in total

1.  Nitrofurantoin and pregnancy.

Authors:  Nevio Cimolai; Tomas Cimolai
Journal:  CMAJ       Date:  2007-06-19       Impact factor: 8.262

2.  Urinary tract infections in pregnancy.

Authors:  Monica Lee; Pina Bozzo; Adrienne Einarson; Gideon Koren
Journal:  Can Fam Physician       Date:  2008-06       Impact factor: 3.275

Review 3.  Nitrofurantoin and glucose-6-phosphate dehydrogenase deficiency: a safety review.

Authors:  Judith Recht; Vilada Chansamouth; Nicholas J White; Elizabeth A Ashley
Journal:  JAC Antimicrob Resist       Date:  2022-05-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.